• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自身免疫性疾病进展中的检查点:来自糖尿病模型的经验教训。

Checkpoints in the progression of autoimmune disease: lessons from diabetes models.

作者信息

André I, Gonzalez A, Wang B, Katz J, Benoist C, Mathis D

机构信息

Institut de Génétique et de Biologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique/Institut National de la Santé et de la Recherche Médicale/Université Louis Pasteur, Strasbourg, France.

出版信息

Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2260-3. doi: 10.1073/pnas.93.6.2260.

DOI:10.1073/pnas.93.6.2260
PMID:8637860
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC39783/
Abstract

In the last few years, data from experiments employing transgenic models of autoimmune disease have strengthened a particular concept of autoimmunity: disease results not so much from cracks in tolerance induction systems, leading to the generation of anti-self repertoire, as from the breakdown of secondary systems that keep these cells in check. T cells with anti-self specificities are readily found in disease-free individuals but ignore target tissues. This is also the case in some transgenic models, in spite of overwhelming numbers of autoreactive cells. In other instances, local infiltration and inflammation result, but they are well tolerated for long periods of time and do not terminally destroy target tissue. We review the possible molecular and cellular mechanisms that underlie these situations, with a particular emphasis on the destruction of pancreatic beta cells in transgenic models of insulin-dependent disease.

摘要

在过去几年中,利用自身免疫性疾病转基因模型进行实验所获得的数据强化了一种特定的自身免疫概念:疾病与其说是由于耐受性诱导系统出现缺陷从而导致产生抗自身抗体库,不如说是由于维持这些细胞平衡的二级系统发生故障所致。具有抗自身特异性的T细胞在无病个体中很容易被发现,但它们会忽略靶组织。在一些转基因模型中也是如此,尽管存在大量的自身反应性细胞。在其他情况下,会出现局部浸润和炎症,但它们在很长一段时间内都能被很好地耐受,不会最终破坏靶组织。我们回顾了这些情况背后可能的分子和细胞机制,特别强调了胰岛素依赖型疾病转基因模型中胰腺β细胞的破坏。

相似文献

1
Checkpoints in the progression of autoimmune disease: lessons from diabetes models.自身免疫性疾病进展中的检查点:来自糖尿病模型的经验教训。
Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2260-3. doi: 10.1073/pnas.93.6.2260.
2
[Viral antigen induced autoimmunity: an animal model for diabetes mellitus type I].[病毒抗原诱导的自身免疫:1型糖尿病的动物模型]
Verh Dtsch Ges Pathol. 1994;78:177-9.
3
Autoimmune disease. Gadding around the beta cell.自身免疫性疾病。围绕β细胞游走。
Curr Biol. 1994 Feb 1;4(2):158-60. doi: 10.1016/s0960-9822(94)00038-2.
4
Prevention of type 1 diabetes.1型糖尿病的预防。
Med Clin North Am. 1998 Jul;82(4):739-55. doi: 10.1016/s0025-7125(05)70022-5.
5
T-cell receptor-transgenic NOD mice: a reductionist approach to understand autoimmune diabetes.T细胞受体转基因非肥胖糖尿病小鼠:一种理解自身免疫性糖尿病的简化方法。
J Autoimmun. 2004 Mar;22(2):121-9. doi: 10.1016/j.jaut.2003.10.003.
6
Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness.在胰腺β细胞上同时表达B7-1和病毒糖蛋白以及糖蛋白特异性转基因T细胞的小鼠,由于T淋巴细胞无反应性的破坏而患上糖尿病。
Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3137-41. doi: 10.1073/pnas.91.8.3137.
7
Autoimmune disorders in diabetes.糖尿病中的自身免疫性疾病。
Adv Nephrol Necker Hosp. 1986;15:281-305.
8
Using transgenic mouse models to dissect the pathogenesis of virus-induced autoimmune disorders of the islets of Langerhans and the central nervous system.利用转基因小鼠模型剖析病毒诱导的胰岛和中枢神经系统自身免疫性疾病的发病机制。
Immunol Rev. 1996 Aug;152:111-43. doi: 10.1111/j.1600-065x.1996.tb00913.x.
9
The TCR-HA, INS-HA transgenic model of autoimmune diabetes: limitations and expectations.自身免疫性糖尿病的TCR-HA、INS-HA转基因模型:局限性与期望
J Autoimmun. 2004 Mar;22(2):111-4. doi: 10.1016/j.jaut.2003.10.005.
10
Presented antigen from damaged pancreatic beta cells activates autoreactive T cells in virus-mediated autoimmune diabetes.在病毒介导的自身免疫性糖尿病中,受损胰腺β细胞呈递的抗原激活自身反应性T细胞。
J Clin Invest. 2002 Jan;109(1):79-87. doi: 10.1172/JCI11198.

引用本文的文献

1
The application and discovery of animal models in enterovirus research.动物模型在肠道病毒研究中的应用与发现
Arch Virol. 2025 Jul 8;170(8):175. doi: 10.1007/s00705-025-06367-6.
2
Targeted animal models for preclinical assessment of cellular and gene therapies in pancreatic and liver diseases: regulatory and practical insights.用于胰腺和肝脏疾病细胞及基因治疗临床前评估的靶向动物模型:监管与实践见解
Cytotherapy. 2025 Mar;27(3):259-278. doi: 10.1016/j.jcyt.2024.11.008. Epub 2024 Nov 19.
3
Immunopeptidome mining reveals a novel ERS-induced target in T1D.免疫肽组学挖掘揭示了 T1D 中一种新型 ERS 诱导的靶标。
Cell Mol Immunol. 2024 Jun;21(6):604-619. doi: 10.1038/s41423-024-01150-0. Epub 2024 Apr 30.
4
Mutations from patients with IPEX ported to mice reveal different patterns of FoxP3 and Treg dysfunction.将来自 IPEX 患者的突变导入小鼠中,揭示了不同的 FoxP3 和 Treg 功能障碍模式。
Cell Rep. 2023 Aug 29;42(8):113018. doi: 10.1016/j.celrep.2023.113018. Epub 2023 Aug 21.
5
Vitamin D in Diabetes: Uncovering the Sunshine Hormone's Role in Glucose Metabolism and Beyond.维生素 D 与糖尿病:探究阳光荷尔蒙在葡萄糖代谢及其他方面的作用。
Nutrients. 2023 Apr 21;15(8):1997. doi: 10.3390/nu15081997.
6
Formation of pancreatic β-cells from precursor cells contributes to the reversal of established type 1 diabetes.前体细胞分化为胰腺β细胞有助于逆转已确立的 1 型糖尿病。
Cell Immunol. 2021 Jun;364:104360. doi: 10.1016/j.cellimm.2021.104360. Epub 2021 Apr 9.
7
Enteroviral Pathogenesis of Type 1 Diabetes: The Role of Natural Killer Cells.1型糖尿病的肠道病毒发病机制:自然杀伤细胞的作用。
Microorganisms. 2020 Jul 1;8(7):989. doi: 10.3390/microorganisms8070989.
8
Hybrid lipids, peptides, and lymphocytes: new era in type 1 diabetes research.混合脂质、肽和淋巴细胞:1 型糖尿病研究的新时代。
J Clin Invest. 2019 Aug 5;12(9):9. doi: 10.1172/JCI130313.
9
CRIg, a tissue-resident macrophage specific immune checkpoint molecule, promotes immunological tolerance in NOD mice, via a dual role in effector and regulatory T cells.CRIg,一种组织驻留巨噬细胞特异性免疫检查点分子,通过在效应和调节性 T 细胞中发挥双重作用,促进 NOD 小鼠的免疫耐受。
Elife. 2017 Nov 24;6:e29540. doi: 10.7554/eLife.29540.
10
Targeting innate immunity to downmodulate adaptive immunity and reverse type 1 diabetes.靶向先天免疫以下调适应性免疫并逆转1型糖尿病。
Immunotargets Ther. 2017 May 19;6:31-38. doi: 10.2147/ITT.S117264. eCollection 2017.

本文引用的文献

1
Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-alpha.糖尿病的诱发受感染病毒以及主要组织相容性复合体I类分子和肿瘤坏死因子-α的局部表达影响。
J Immunol. 1993 Jun 1;150(11):5185-94.
2
Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.小鼠中转化生长因子β1基因无效突变会导致过度炎症反应和早期死亡。
Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):770-4. doi: 10.1073/pnas.90.2.770.
3
Prevention of autoimmune type I diabetes by CD4+ suppressor T cells in superantigen-treated non-obese diabetic mice.
J Immunol. 1993 Oct 15;151(8):4362-70.
4
Following a diabetogenic T cell from genesis through pathogenesis.追踪致糖尿病T细胞从起源到发病的过程。
Cell. 1993 Sep 24;74(6):1089-100. doi: 10.1016/0092-8674(93)90730-e.
5
Altered cytokine activity in adjuvant inhibition of autoimmune diabetes.佐剂抑制自身免疫性糖尿病过程中细胞因子活性的改变
J Autoimmun. 1993 Jun;6(3):291-300. doi: 10.1006/jaut.1993.1025.
6
T-cell autoimmunity in type 1 diabetes mellitus.1型糖尿病中的T细胞自身免疫。
Curr Opin Immunol. 1993 Dec;5(6):903-9. doi: 10.1016/0952-7915(93)90104-z.
7
Islet-specific T-cell clones from the NOD mouse respond to beta-granule antigen.来自非肥胖糖尿病(NOD)小鼠的胰岛特异性T细胞克隆对β颗粒抗原产生反应。
Diabetes. 1994 Feb;43(2):197-203. doi: 10.2337/diab.43.2.197.
8
Isolation of nonobese diabetic mouse T-cells that recognize novel autoantigens involved in the early events of diabetes.分离识别参与糖尿病早期事件的新型自身抗原的非肥胖糖尿病小鼠T细胞。
Diabetes. 1994 Jan;43(1):33-9. doi: 10.2337/diab.43.1.33.
9
Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.对谷氨酸脱羧酶的免疫反应与非肥胖糖尿病小鼠的胰岛炎相关。
Nature. 1993 Nov 4;366(6450):72-5. doi: 10.1038/366072a0.
10
Expression of homing and adhesion molecules in infiltrated islets of Langerhans and salivary glands of nonobese diabetic mice.归巢和黏附分子在非肥胖糖尿病小鼠浸润的胰岛和唾液腺中的表达。
J Immunol. 1994 Jun 15;152(12):5969-78.